Skip to main content

Peer Review reports

From: Activity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020–2022)

Original Submission
4 Apr 2024 Submitted Original manuscript
30 Jul 2024 Author responded Author comments - Helio S. Sader
Resubmission - Version 2
30 Jul 2024 Submitted Manuscript version 2
8 Aug 2024 Author responded Author comments - Helio S. Sader
Resubmission - Version 3
8 Aug 2024 Submitted Manuscript version 3
24 Sep 2024 Reviewed Reviewer Report
2 Oct 2024 Reviewed Reviewer Report - Kimberly Leuthner
22 Oct 2024 Reviewed Reviewer Report
28 Oct 2024 Author responded Author comments - Helio S. Sader
Resubmission - Version 4
28 Oct 2024 Submitted Manuscript version 4
23 Nov 2024 Author responded Author comments - Helio S. Sader
Resubmission - Version 5
23 Nov 2024 Submitted Manuscript version 5
5 Dec 2024 Author responded Author comments - Helio S. Sader
Resubmission - Version 6
5 Dec 2024 Submitted Manuscript version 6
20 Dec 2024 Author responded Author comments - Helio S. Sader
Resubmission - Version 7
20 Dec 2024 Submitted Manuscript version 7
9 Jan 2025 Author responded Author comments - Helio S. Sader
Resubmission - Version 8
9 Jan 2025 Submitted Manuscript version 8
Publishing
13 Jan 2025 Editorially accepted
24 Jan 2025 Article published 10.1186/s12890-025-03500-8

You can find further information about peer review here.

Back to article page